Direct-to-consumer prescription drug advertising and the public

Journal of General Internal Medicine

Volumn 14, Issue 11, 1999, Pages 651-657

  Bell, Robert A ^a   Kravitz, Richard L ^a   Wilkes, Michael S ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Advertising; Drug promotion; Drug regulation; Drug safety; Prescription drugs

Indexed keywords

ALENDRONIC ACID; BUSPIRONE; FLUOXETINE; ITRACONAZOLE; LORATADINE; METFORMIN; OMEPRAZOLE; PRAVASTATIN; SUMATRIPTAN SUCCINATE; ZAFIRLUKAST;

ARTICLE; DRUG INFORMATION; DRUG MARKETING; DRUG SAFETY; HUMAN; MASS MEDIUM; PRESCRIPTION; TREATMENT INDICATION;

ADULT; ADVERTISING; CALIFORNIA; DATA COLLECTION; DRUG INDUSTRY; FEMALE; HUMANS; MALE; MIDDLE AGED; PRESCRIPTIONS, DRUG; RANDOM ALLOCATION; TERMINOLOGY;

EID: 0032735689     PISSN: 08848734     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1525-1497.1999.01049.x     Document Type: Article

References (25)

1. 1. Mueller C, Schur C, O'Connell J. Prescription drug spending: the impact of age and chronic disease status. Am J Public Health. 1997;87:1626-9.
2. 2. Glaquinta D. Drug formularies - good or evil? A view from a managed care provider. Cardiology. 1994;85(suppl 1):30-5.
3. 3. Jaklevic MC. Prescribed cutback: HMOs shift risk to doc groups to curb drug utilization. Mod Healthcare. 1997;27(29):34.
4. 4. Growth seen in ads for direct-to-consumer drugs. Am Med News. April 27, 1998:16.
5. 5. 't Hoen E. Direct-to-consumer advertising: for better profits or for better health? Am J Health-System Pharmacy. 1998;55:594-7.
6. 6. Alperstein NM, Peyrot M. Consumer awareness of prescription drug advertising. J Advertising Res. 1993;33(4):50-6.
7. 7. Rogers EM. Diffusion of Innovations. 3rd ed. New York, NY: The Free Press; 1983:241-70.
8. 8. Bradley L, Zito JM. Direct-to-consumer prescription drug adverUsing. Med Care. 1997;35:86-92.
9. 9. Waksberg J. Sampling methods for random digit dialing. J Am Stat Assoc. 1978;73:40-6.
10. 10. Hagen DE, Collier CM. Must respondent selection procedures for telephone surveys be invasive? Public Opin Q. 1983;47:547-56.
11. 11. Cronbach LJ. Coefficient alpha and the internal structure of tests. Psychometrika. 1951;16:297-334.
12. 12. Carmines EG, Zeller RA. Reliability and Validity Assessment. Newbury Park, Calif: Sage; 1979.
13. 13. Ware JE Jr. SF-36 Health Survey: Manual And Interpretation. Boston, Mass: The Health Institute, New England Medical Center; 1993.
14. 14. Bentler PM, Wu EJC. EQS for Windows Users Guide. Encino, Calif: Multivariate Software, Inc.; 1995.
15. 15. Hosmer DW, Lemeshow S. Applied Logistic Regression. New York, NY: John Wiley; 1989.
16. 16. Everett SE. Lay audience response to prescription drug advertising. J Advertising Res. 1991;31(2):43-9.
17. 17. Nordenberg T. Direct to you: TV drug ads that make sense. FDA Consumer. 1998;32:7.
18. 18. O'Keefe DJ. Persuasion: Theory and Research. Newbury Park, Calif: Sage; 1990.
19. 19. Morris LA, Brinberg D, Klimberg R, Rivera C, Millstein LG, Miscomprehension rates for prescription drug advertisements. Curr Issues Res Advertising. 1986;9(1,2):93-117.
20. 20. Morris LA, Brinberg D, Klimberg R, Millstein L, Rivera C. Consumer attitudes about advertisements for medicinal drugs. Soc Sci Med. 1986;22:629-38.
21. 21. Percy L, Rossiter JR. A model of brand awareness and brand attitude advertising strategies. Psychol Marketing. 1992;9:263-74.
22. 22. Sitthi-Amorn C, Ngamvithayapongse J. The role of media and communication in improving the use of drugs and other technologies. Int J Technol Assess Health Care. 1998;14:71-80.
23. 23. Wilkes MS, Doblin BH, Shapiro MF. Pharmaceutical advertisements in leading medical journals: Experts' assessments. Ann Intern Med. 1992;116:912-9.
24. 24. Lexchin J. What information do physicians receive from pharmaceutical representatives? Can Fam Physician. 1997;43:941-5.
25. 25. Vener AM, Krupka LR. Over-the-counter drug advertising in gender oriented popular magazines. J Drug Educ. 1986;16:367-81.